Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program

被引：7
|
作者：
Kelm, Ryan C. [1 ]
Hagstrom, Erika L. [1 ]
Mathieu, Regine J. [1 ]
Orrell, Kelsey A. [1 ]
Serrano, Linda [1 ]
Mueller, Kelly A. [1 ]
Laumann, Anne E. [1 ]
West, Dennis P. [1 ,2 ]
Nardone, Beatrice [1 ]
机构：
[1] Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA
[2] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 80卷 / 03期
基金：
美国国家卫生研究院;
关键词：
COMPLICATING TREATMENT;
D O I：
10.1016/j.jaad.2018.10.052
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：820 / 821
页数：3
相关论文
共 50 条
  • [41] Frequency of depression in dermatologist-managed patients who have acne, isotretinoin-exposure vs no isotretinoin exposure: Pharmacovigilance analysis of a large Midwestern US population from the RADAR (Research on Adverse Drug events And Reports) program
    Soundararajan, Vinaya
    Gwillim, Eran
    Lefferdink, Rachel
    Schlosser, Bethanee
    West, Dennis P.
    Nardone, Beatrice
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB67 - AB67
  • [42] Reporting of cancer clinical trial adverse drug events: A RADAR report
    Belknap, S. M.
    Georgopoulos, C. H.
    Weitzman, S. A.
    Qualkenbush, L.
    Samaras, A. T.
    McKoy, J. M.
    Edwards, B. J.
    Rosen, S. T.
    West, D. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Hypersensitivity cases associated with drug-eluting coronary stents - A review of available cases from the research on adverse drug events and reports (RADAR) project
    Nebeker, JR
    Virmani, R
    Bennett, CL
    Hoffman, JM
    Samore, MH
    Alvarez, J
    Davidson, CJ
    McKoy, JM
    Raisch, DW
    Whisenant, BK
    Yarnold, PR
    Belknap, SM
    West, DP
    Gage, JE
    Morse, RE
    Gligoric, G
    Davidson, L
    Feldman, MD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) : 175 - 181
  • [44] Erythropoiesis stimulating agents (ESAs): An overview of safety-related findings from the Research on Adverse Drug Events and Reports (RADAR) project
    McKoy, J. M.
    Sartor, A. O.
    Henke, M.
    West, D. P.
    Courtney, D. M.
    Carson, K. R.
    Edwards, B. J.
    Samaras, A. T.
    Bennett, C. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project
    McKoy, June M.
    Angelotta, Cara
    Bennett, Charles L.
    Tallman, Martin S.
    Wadleigh, Martha
    Evens, Andrew M.
    Kuzel, Timothy M.
    Trifilio, Steve M.
    Raisch, Dennis W.
    Kell, Jonathan
    DeAngelo, Daniel J.
    Giles, Francis J.
    [J]. LEUKEMIA RESEARCH, 2007, 31 (05) : 599 - 604
  • [46] The research on Adverse Drug Events and reports (RADAR) evaluation of the quality of reports to the FDA's MedWatch system for oncology related adverse drug reactions (ADRs): Extensive improvements are needed.
    Bennett, CL
    Morse, RE
    Carson, KR
    Belknap, S
    Raisch, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 535S - 535S
  • [47] Clinical trials, case reports, and observational databases as sources of information on serious cancer-related adverse drug reactions (sADRs): Lessons learned from the Research on Adverse Drug Events and Reports (RADAR) project
    Bennett, C.
    Gleason, K.
    Djulbegovic, B.
    Raisch, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Malignant melanoma associated with chronic once-daily aspirin exposure in males: A large, single-center, urban, US patient population cohort study from the "Research on Adverse Drug events And Report" (RADAR) project
    Orrell, Kelsey A.
    Cices, Ahuva D.
    Guido, Nicholas
    Majewski, Sara
    Ibler, Erin
    Huynh, Thy
    Rangel, Stephanie M.
    Laumann, Anne E.
    Martini, Mary C.
    Rademaker, Alfred W.
    West, Dennis P.
    Nardone, Beatrice
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : 762 - 764
  • [49] Bullous skin disorders associated with PD-1 and PDL-1 inhibitors: Pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) from the Research on Adverse Drug events And Reports (RADAR) Program
    Jimenez, Javier
    Nardone, Beatrice
    Kosche, Cory
    Rauck, Corinne
    Rangel, Stephanie M.
    West, Dennis P.
    Lacouture, Mario E.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB29 - AB29
  • [50] Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group
    Evens, AM
    Bennett, CL
    Luminari, S
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (03) : 481 - 489
12345